Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Clinical Microbiology|August 1, 1980
Production of phenylacetic acid by strains of Bacteroides asaccharolyticus and Bacteroides gingivalis (sp. nov.)F S Kaczmarek, A L Coykendall
Microbiology (Reading, England)|June 1, 1994
Characterization of a Streptomyces-lividans-type site-specific DNA modification system in the avermectin-producer Streptomyces avermitilis permits investigation of two novel giant linear plasmids, pSA1 and pSA2M Evans, F S Kaczmarek, K Stutzman-Engwall, et al.
Biochemistry|March 8, 2000
Action of quinolones against Staphylococcus aureus topoisomerase IV: basis for DNA cleavage enhancementV E Anderson, R P Zaniewski, F S Kaczmarek, et al.
The Journal of Biological Chemistry|December 10, 1999
Quinolones inhibit DNA religation mediated by Staphylococcus aureus topoisomerase IV. Changes in drug mechanism across evolutionary boundariesV E Anderson, R P Zaniewski, F S Kaczmarek, et al.
Antimicrobial Agents and Chemotherapy|August 3, 1999
Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureusT D Gootz, R P Zaniewski, S L Haskell, et al.
Molecular & General Genetics : MGG|January 1, 1989
Molecular cloning of resistance genes and architecture of a linked gene cluster involved in biosynthesis of oxytetracycline by Streptomyces rimosusM J Butler, E J Friend, I S Hunter, et al.
Journal of Bacteriology|October 1, 1987
Cloning and sequencing of the alkaline extracellular protease gene of Yarrowia lipolyticaL S Davidow, M M O'Donnell, F S Kaczmarek, et al.
Archives of Virology|January 1, 1979
Comparative properties of the inclusion body proteins of the nucleopolyhedrosis viruses of Neodiprion sertifer and Lymantria disparS E Brown, F S Kaczmarek, N R Dubois, et al.
Current Genetics|January 1, 1987
The Yarrowia lipolytica LEU2 geneL S Davidow, F S Kaczmarek, J R DeZeeuw, et al.
Biochimica Et Biophysica Acta|January 19, 1990
Expression of human plasminogen activator inhibitor type-1 (PAI-1) in Escherichia coli as a soluble protein comprised of active and latent forms. Isolation and crystallization of latent PAI-1A E Franke, D E Danley, F S Kaczmarek, et al.
Pageof 2